1. Home
  2. APAM vs QURE Comparison

APAM vs QURE Comparison

Compare APAM & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

APAM

Artisan Partners Asset Management Inc.

HOLD

Current Price

$41.57

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$44.50

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APAM
QURE
Founded
1994
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.2B
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
APAM
QURE
Price
$41.57
$44.50
Analyst Decision
Hold
Buy
Analyst Count
5
14
Target Price
$43.00
$45.00
AVG Volume (30 Days)
691.8K
1.1M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
10.81%
N/A
EPS Growth
10.66
29.67
EPS
1.90
N/A
Revenue
$1,196,688,000.00
$13,107,000.00
Revenue This Year
$5.96
$126.12
Revenue Next Year
$5.05
$200.43
P/E Ratio
$21.67
N/A
Revenue Growth
7.63
N/A
52 Week Low
$33.96
$8.73
52 Week High
$46.53
$71.50

Technical Indicators

Market Signals
Indicator
APAM
QURE
Relative Strength Index (RSI) 46.24 43.92
Support Level $40.46 $39.50
Resistance Level $42.74 $51.09
Average True Range (ATR) 1.00 2.09
MACD -0.36 -0.66
Stochastic Oscillator 19.90 6.76

Price Performance

Historical Comparison
APAM
QURE

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. The company operates as one segment in the investment management business. The company generates maximum portion of its revenues from clients domiciled in countries outside the United States.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: